MaxCyte is proud to participate in the 2nd Annual Gene Therapy Initiative Symposium at the Salk Institute on September 18, 2025, spotlighting our leading non-viral electroporation technologies that empower scalable gene and cell therapy development. We look forward to engaging with peers during the panel sessions and networking hour to foster collaboration and accelerate the translation of innovative therapies